Related Experiment Video
Updated: Jun 26, 2026

The Use of the Ex Vivo Chandler Loop Apparatus to Assess the Biocompatibility of Modified Polymeric Blood Conduits
Published on: August 20, 2014
The effect of chelation on blood pressure in lead-exposed children: a randomized study
Aimin Chen1, George G Rhoads, Bo Cai
1Epidemiology Branch, National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services, Research Triangle Park, NC 27709, USA.
Insights
This study found no link between moderately high blood lead levels and blood pressure in young children. Succimer treatment did not alter blood pressure, even when it lowered lead levels.
Area of Science:
- Environmental Health
- Pediatrics
- Toxicology
Background:
- Previous studies suggest a weak link between blood lead concentration and blood pressure in children.
- The impact of lead exposure on cardiovascular health in pediatric populations requires further investigation.
Purpose of the Study:
- To examine the association between blood lead concentration and blood pressure in children with elevated lead levels.
- To determine if succimer chelation therapy affects blood pressure in these children.
Main Methods:
- A randomized clinical trial involving 780 children aged 12-33 months with blood lead concentrations of 20-44 microg/dL.
- Comparison of systolic and diastolic blood pressure between a succimer-treated group and a placebo group over a 5-year follow-up period.
- Analysis of the relationship between blood lead levels and blood pressure.
Main Results:
- Succimer treatment effectively lowered blood lead concentrations for 9-10 months but did not significantly alter blood pressure during this period.
- Over 1-5 years, the succimer group showed a slight increase in systolic blood pressure (1.09 mmHg) compared to the placebo group, but diastolic blood pressure differences were not significant.
- No overall association was found between blood lead concentration and blood pressure in children with moderately high lead exposure.
Conclusions:
- There is no discernible association between blood lead concentration and blood pressure in children experiencing moderately high lead exposure.
- Chelation therapy with succimer does not appear to influence blood pressure in this pediatric cohort.
Abstract:
Studies in children suggest a weak association between blood lead concentration and blood pressure. To understand this better, we tested the strength of the association in children with elevated blood lead concentrations and whether succimer chelation changed blood pressure as it did blood lead. In a randomized clinical trial of 780 children with blood lead concentrations of 20-44 microg/dL at 12-33 months of age, we compared the systolic and diastolic blood pressure in the succimer-treated group and placebo group for up to 5 years of follow-up. We also analyzed the relation of blood lead to blood pressure. Children in the succimer group had lower blood lead concentrations for 9-10 months during and after treatment, but their blood pressure did not differ from those in the placebo group during this period. During 1-5 years of follow-up, children in the succimer group had systolic blood pressure 1.09 (95% confidence interval, 0.27-1.90) mmHg higher than did untreated children in a model with repeated measurements, but the difference in diastolic blood pressure was not statistically significant. No association between blood lead and blood pressure was found. Overall, there is no association between blood lead and blood pressure in these children with moderately high lead exposure, nor does chelation with succimer change blood pressure.
More Related Videos
Related Concept Videos
Solubility Equilibria
The...
Factors Affecting Solubility
Complexation Equilibria: The Chelate Effect
Extraction: Advanced Methods
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

